Über das Unternehmen
- Firmenname (rechtlich): Chongqing Carelife Pharmaceutical
- Registrierungsland: China
- Adresse: 3 Hua Nanyi Road, Chongqing (Changshou) Chemical Industrial Park; China Chong...
- Anzahl der Mitarbeiter: 250 - 499
Beschreibung:
Carelife is a high-tech enterprise integrating R&D, production and sales of APIs, operating two state-of-the-art manufacturing facilities compliant with international and Chinese cGMP standards. The company's rigorous quality assurance system has earned inspections and approvals from the US FDA, EDQM, Japan's PMDA, German health authorities, Australia's TGA, Canada's TPD, India's Ministry of Health and China's FDA.
Geschäftsaktivitäten
Pharmazeutische Wirkstoffe (API)
Hersteller
ATC-Klassifikation (Anatomisch-Therapeutisch-Chemisch)
HerstellerAPI-Hersteller
Absatzmärkte
- Northern Europe: Denmark, Estonia, Finland, Ireland, Latvia, Lithuania, Sweden
- Southern Europe: Croatia, Greece, Italy, Malta, Portugal, Slovenia, Spain
- Eastern Europe: Bulgaria, Czech Republic, Hungary, Poland, Romania, Slovakia
- Western Europe: Austria, Belgium, France, Germany, Luxembourg, Netherlands
- Northern America: Bermuda, Canada, Greenland, Saint Pierre and Miquelon
Hauptprodukte/-dienstleistungen
- ATC-Klassifikation (Anatomisch-Therapeutisch-Chemisch): Palbociclib, Bortezomib, Regorafenib, Dolutegravir Sodium, Iron Sucrose, FERRIC CARBOXYMALTOSE, Tranexamic Acid, Granisetron HCl, Canagliflozin Monohydrate, Finerenone, Cabotegravir, Entecavir Hydrate, Tenofovir Alafenamide Fumarate, Lenvatinib Mesylate, Dacomitinib, Sorafenib Tosylate, Pemetrexed disodium, Nusinersen Sodium, Epinastine HCl
Unsere Produkte & Dienstleistungen
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Certifications
DMF
Sonstiges
CE
FDA
GMP
ISO
Proofs
CPHI & PMEC China 2026
06/2026 – 06/2026
CPHI & PMEC China 2026
Bewertungen
(0)
(0)
(0)
(0)
(0)
Kommentare
Filter:
Sortieren nach:
Keine Kommentare verfügbar.
Bewertung & Kommentar hinterlassen